Key points are not available for this paper at this time.
Among the priorities for the European health directorate, DG Sanco, as it takes control of the agency in charge of drug regulation should be to end the secrecy surrounding approval decisions, say Silvio Garattini and Vittorio Bertele’
Garattini et al. (2010) studied this question.